3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
198
Leukemia, Lymphocytic, Chronic, B-Cell
48
Myelodysplastic Syndromes
39
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Recurrence
27
Leukemia
26
Lymphoma, Mantle-Cell
22
Leukemia, Myelomonocytic, Chronic
16
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Biphenotypic, Acute
15
Lymphoma, Follicular
14
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
12
Burkitt Lymphoma
12
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Neoplasm, Residual
9
Hematologic Neoplasms
9
Multiple Myeloma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Waldenstrom Macroglobulinemia
5
Neoplasms
5
Lymphoma, B-Cell
5
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Leukemia, B-Cell
4
Immunoglobulin Light-chain Amyloidosis
4
Blast Crisis
4
Interventions
Cyclophosphamide
54
Tacrolimus
50
Methotrexate
36
Mycophenolic Acid
34
fludarabine phosphate
33
Busulfan
31
Cyclosporine
29
fludarabine
28
Antilymphocyte Serum
28
Melphalan
23
Sirolimus
21
Whole-Body Irradiation
18
Radiotherapy
18
Peripheral Blood Stem Cell Transplantation
18
Methylprednisolone
18
Filgrastim
15
thymoglobulin
13
Thiotepa
10
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
8
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Cytarabine
6
Alemtuzumab
6
ruxolitinib
5
Transplantation
5
Therapeutics
5
Prednisone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Graft vs Host Disease
×
venetoclax
×
Clear all
NCT05005299
2023-08-01
VICTORY
Melbourne Health
Phase 1
Unknown
18 enrolled